CN1182604A - Ointment for treating apoplexy - Google Patents
Ointment for treating apoplexy Download PDFInfo
- Publication number
- CN1182604A CN1182604A CN 96122266 CN96122266A CN1182604A CN 1182604 A CN1182604 A CN 1182604A CN 96122266 CN96122266 CN 96122266 CN 96122266 A CN96122266 A CN 96122266A CN 1182604 A CN1182604 A CN 1182604A
- Authority
- CN
- China
- Prior art keywords
- radix
- ointment
- treating apoplexy
- raw materials
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of compound ointment for breating apoplexy, which is mainly composed of Chinese angelica, Ligusticum wallchii, unpeeled root of heraceous peony, root of membranous milk vetch, leech, root of red-rooted salvia, notopterygium, licorice root etc. It is beneficial to the supply of the nutrition and oxygen to the cells of cardiacmuscle and brain. Through clinical observation, it can cure the cerebrocardiac thrombosis and infarction. It is obviously effective for the cerebrovascular disease both at acute stage, recovery stage and sequel stage.
Description
The invention belongs to compound Chinese patent medicine, relate to a kind of Ointment for treating apoplexy.
Apoplexy (apoplexy) is one of three big diseases of world today's harm humans health.In China and the Japanese first place that occupies the dead cause of disease.The cause of disease understanding of apoplexy is shown the gold dollar epoch greatly and is divided, and many before relatively exopathogenic factors are said, then are partial to theory of the internal origin afterwards.Gold dollar epoch Liu's interchannel is advocated " heart-fire is contained cruelly ".Li Dongyuan thinks " healthy energy is from empty ".Zhu Danxi thinks genus " damp and hot living expectorant ".Unit's Deity is carried out primary disease is belonged to " syndrome similar to wind disease ", thinks: " people when four ten days weakness of QIs, or hinder its gas person because of melancholy happiness anger, this disease is arranged more." Ming Dynasty Zhang Jingyue work " non-wind opinion ", advocate saying of apoplexy " non-wind ": " this all internal injury long-pending decrease declining and right, due to the former non-affection of exogenous wind-cold ".The understanding that clear early years, the sky scholar managed apoplexy is more clear and definite, says: " essence and blood attenuation, the kidney failing to nourish the liver ... liver-yang is high partially, rises during endogenous wind ".Clear Wang Qingren work errors in Medicine Corrected is said so that the deficiency of vital energy is upright, and treated hemiplegia with BUYANG HUANWU TANG, and is evident in efficacy.Afterwards, Tang Rongchuan work " treatise on blood trouble " to the blood circulation promoting and blood stasis dispelling theory of Wang Qingren, improves and raising to some extent.At present, following method is mainly used to the treatment of apoplexy in countries in the world: (1) Drug therapy; (2) operative treatment; (3) Comprehensive Treatment comprises the therapeutic physical education therapy.Wherein, used medicine is used various chemical synthetic drugs more, and the medicine toxicity, side effect is big, and the improper use meeting causes other diseases.In recent years, though use the Chinese medicine primary disease certain progress is arranged, it is equally matched how curative effect is compared with Western medicine, but less to the research of pharmacology aspect, and the rehabilitation of apoplexy is affected.
The objective of the invention is to: provide a kind of compound Chinese patent medicine by blood circulation promoting and blood stasis dispelling, collateral dredging QI invigorating to come efficient, safety, economy, treat the natural Ointment for treating apoplexy of each interim syndrome caused by wind pathogen easily.
Purpose of the present invention can realize by following measure:
A kind of Ointment for treating apoplexy is the ointment of being made according to the conventional formulation method by the raw material of following weight hundred content:
Radix Angelicae Sinensis 30-40% Rhizoma Chuanxiong 9-15% Radix Paeoniae Rubra 6-9% Radix Astragali 15-20%
Hirudo 4-7% Radix Salviae Miltiorrhizae 5-10% Rhizoma Et Radix Notopterygii 5-10% Radix Glycyrrhizae 3-5%.
Purpose of the present invention also can realize by following measure:
Rhizoma Chuanxiong can be used a kind of replacement in Flos Carthami, Semen Persicae, the Lignum Sappan in the composition of raw materials of Ointment for treating apoplexy, and its formulation weight percentage composition is constant.Described Radix Paeoniae Rubra can be used a kind of replacement in the Radix Paeoniae Alba, Colla Corii Asini, the Placenta Hominis, and its formulation weight percentage composition is constant.Described Rhizoma Et Radix Notopterygii can be used a kind of replacement in Radix Angelicae Pubescentis, Ramulus Cinnamomi, the Radix Saposhnikoviae, and its formulation weight percentage composition is constant.
Be that to invigorate blood circulation with Chinese Angelica blood replonishing be monarch in the Ointment for treating apoplexy prescription of the present invention, with Rhizoma Chuanxiong, Radix Paeoniae Rubra, Radix Astragali activating blood circulation and supplementing qi is minister, be aided with Hirudo, Radix Salviae Miltiorrhizae, Rhizoma Et Radix Notopterygii with the effect that strengthens its promoting blood circulation to remove obstruction in the collateral for making, use the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, we have worked in coordination with the effect of benefiting QI and nourishing blood, disperse blood stasis and dredge collateral through reasonable compatibility.
Ointment for treating apoplexy of the present invention shows that through clinical use result it has following advantage compared to existing technology:
Ointment for treating apoplexy of the present invention has the ratio of tangible reduction whole blood viscosity and plasma viscosity, shortens erythrocyte electrophoretic time; Anticoagulant promotes the platelet depolymerization; Microcirculation improvement and releasing microcirculation disturbance.These effects show that Ointment for treating apoplexy has blood circulation invigorating efficacies, help the nutrition of myocardial cell and brain cell and the supply of oxygen, thereby help preventing and treating the formation and the infraction of the heart, cerebral thrombosis.In addition, body's immunity is had dual regulation again, can impel mouse thymus and spleen atrophy, suppress cell immune response, thereby produce antiinflammatory, antiallergic action effect; The tardy allergy that DNCB excited also there is the obvious suppression effect; Can promote the synthetic of immunoglobulin, improve serum antibody and generate, help the localization and the absorption of inflammation, play the effect of " tonify deficiency is helped the weak ".Can make the positive neutrophil cell percentage ratio of peripheral blood NBT obviously improve, reflect the increase of body non-specific immunity again.Thereby the resistance against diseases of embolism class diseases, body and the rehabilitation of disease all there is very important meaning.
Anxious, the long term toxicity test of Ointment for treating apoplexy and clinical experiment, the Shu Faxian toxic reaction.
Picked at random treatment group of the present invention and matched group, the treatment group is taken Ointment for treating apoplexy of the present invention; Matched group adopts comprehensive treatment, promptly uses therapies such as Chinese medicine, Western medicine, physical therapy, hyperbaric oxygen chamber, acupuncture, massage, the qigong.Take method of the present invention: be 1 of every day 200g, molten gradation clothes, be 30 days 1 courses of treatment the course of treatment, treats 1-2 the course of treatment.More than clinical observation 150 examples, the proof Ointment for treating apoplexy all has significant curative effect to cerebrovascular acute stage, convalescent period, sequela stage, total effective rate is 92.76%, wherein acute stage,, total effective rate was 97.30%, convalescent period, total effective rate was 94.12%, the sequela stage total effective rate is 77.78%, and curative effect is better than matched group.
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of Ointment for treating apoplexy is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method: Radix Angelicae Sinensis 31%, Rhizoma Chuanxiong 14%, Radix Paeoniae Rubra 8%, the Radix Astragali 17%, Hirudo 6%, Radix Salviae Miltiorrhizae 10%, Rhizoma Et Radix Notopterygii 10%, Radix Glycyrrhizae 4%.
Embodiment two:
A kind of Ointment for treating apoplexy is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method: Radix Angelicae Sinensis 40%, Flos Carthami 12%, the Radix Paeoniae Alba 9%, the Radix Astragali 20%, Hirudo 4%, Radix Salviae Miltiorrhizae 6%, Radix Angelicae Pubescentis 6%, Radix Glycyrrhizae 3%.
Embodiment three
A kind of Ointment for treating apoplexy is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method: Radix Angelicae Sinensis 36%, Semen Persicae 13%, Colla Corii Asini 7%, the Radix Astragali 19%, Hirudo 5%, Radix Salviae Miltiorrhizae 8%, Ramulus Cinnamomi 8%, Radix Glycyrrhizae 4%.
Embodiment four
A kind of Ointment for treating apoplexy is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method: Radix Angelicae Sinensis 34%, Lignum Sappan 15%, Placenta Hominis 6%, the Radix Astragali 15%, Hirudo 7%, Radix Salviae Miltiorrhizae 9%, Radix Saposhnikoviae 9%, Radix Glycyrrhizae 5%.
Embodiment five:
A kind of Ointment for treating apoplexy is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method: Radix Angelicae Sinensis 38%, Rhizoma Chuanxiong 10%, Radix Paeoniae Rubra 8%, the Radix Astragali 18%, Hirudo 7%, Radix Salviae Miltiorrhizae 7%, Rhizoma Et Radix Notopterygii 7%, Radix Glycyrrhizae 5%.
Claims (4)
1, a kind of Ointment for treating apoplexy is characterized in that it is by the ointment of following raw materials in percentage by weight according to the preparation of conventional formulation method:
Radix Angelicae Sinensis 30-40% Rhizoma Chuanxiong 9-15% Radix Paeoniae Rubra 6-9%
Radix Astragali 15-20% Hirudo 4-7% Radix Salviae Miltiorrhizae 5-10%
Rhizoma Et Radix Notopterygii 5-10% Radix Glycyrrhizae 3-5%.
2, Ointment for treating apoplexy according to claim 1 is characterized in that Rhizoma Chuanxiong in its composition of raw materials can use a kind of replacement in Flos Carthami, Semen Persicae, the Lignum Sappan, and its formulation weight percentage composition is constant.
3, Ointment for treating apoplexy according to claim 1 is characterized in that Radix Paeoniae Rubra in its composition of raw materials can use a kind of replacement in the Radix Paeoniae Alba, Colla Corii Asini, the Placenta Hominis, and its formulation weight percentage composition is constant.
4, Ointment for treating apoplexy according to claim 1 is characterized in that Rhizoma Et Radix Notopterygii in its composition of raw materials can use a kind of replacement in Radix Angelicae Pubescentis, Ramulus Cinnamomi, the Radix Saposhnikoviae, and its formulation weight percentage composition is constant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96122266 CN1182604A (en) | 1996-11-20 | 1996-11-20 | Ointment for treating apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96122266 CN1182604A (en) | 1996-11-20 | 1996-11-20 | Ointment for treating apoplexy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1182604A true CN1182604A (en) | 1998-05-27 |
Family
ID=5127215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96122266 Pending CN1182604A (en) | 1996-11-20 | 1996-11-20 | Ointment for treating apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1182604A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074930C (en) * | 1999-04-20 | 2001-11-21 | 丁志忠 | Prescription of Tongshuanhuoluowan as medicine for thrombolysis and activating collaterals and preparing method thereof |
| CN1101692C (en) * | 2000-09-26 | 2003-02-19 | 袁曙光 | Method for preparing Chinese medicine for curing apoplexy and hemiparalysis |
| CN100388927C (en) * | 2005-01-13 | 2008-05-21 | 鲁南制药集团股份有限公司 | Medicine for treating apoplexy and its preparing process |
| CN100409894C (en) * | 2006-01-24 | 2008-08-13 | 高义武 | Chinese proprietary medicine for treating cerebral thrombosis |
| CN102078441A (en) * | 2010-12-21 | 2011-06-01 | 李永泉 | Pharmaceutical composition for treating hemiplegia |
| CN102389470A (en) * | 2011-11-11 | 2012-03-28 | 吴淑玺 | Traditional Chinese medicinal composition for promoting blood circulation and removing obstructions in channels |
| CN102579610A (en) * | 2012-04-01 | 2012-07-18 | 许从玉 | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof |
| CN103083451A (en) * | 2013-02-21 | 2013-05-08 | 河南中医学院 | Traditional Chinese medical ointment for treating shoulder-hand syndrome as well as preparation method thereof |
| CN103340998A (en) * | 2013-07-29 | 2013-10-09 | 邓森林 | Hand tremble rehabilitation capsules |
| CN104013820A (en) * | 2014-07-01 | 2014-09-03 | 济南高达信息技术有限公司 | Traditional Chinese medicine decoction for treating sequela of cerebral apoplexy |
| CN104622981A (en) * | 2015-01-20 | 2015-05-20 | 甘肃省中医药研究院 | Preparation method of traditional Chinese medicine granules for treating cerebral apoplexy |
| CN105434513A (en) * | 2016-01-03 | 2016-03-30 | 岑溪市坤发液体燃烧炉具有限公司 | Medicated wine for treating stroke sequelae |
| CN109260368A (en) * | 2018-09-26 | 2019-01-25 | 陈晓虎 | The pharmaceutical composition and preparation method thereof for preventing and treating acute coronary syndrome |
-
1996
- 1996-11-20 CN CN 96122266 patent/CN1182604A/en active Pending
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074930C (en) * | 1999-04-20 | 2001-11-21 | 丁志忠 | Prescription of Tongshuanhuoluowan as medicine for thrombolysis and activating collaterals and preparing method thereof |
| CN1101692C (en) * | 2000-09-26 | 2003-02-19 | 袁曙光 | Method for preparing Chinese medicine for curing apoplexy and hemiparalysis |
| CN100388927C (en) * | 2005-01-13 | 2008-05-21 | 鲁南制药集团股份有限公司 | Medicine for treating apoplexy and its preparing process |
| CN100409894C (en) * | 2006-01-24 | 2008-08-13 | 高义武 | Chinese proprietary medicine for treating cerebral thrombosis |
| CN102078441A (en) * | 2010-12-21 | 2011-06-01 | 李永泉 | Pharmaceutical composition for treating hemiplegia |
| CN102078441B (en) * | 2010-12-21 | 2012-01-04 | 李永泉 | Pharmaceutical composition for treating hemiplegia |
| CN102389470A (en) * | 2011-11-11 | 2012-03-28 | 吴淑玺 | Traditional Chinese medicinal composition for promoting blood circulation and removing obstructions in channels |
| CN102389470B (en) * | 2011-11-11 | 2013-06-05 | 吴淑玺 | Traditional Chinese medicinal composition for promoting blood circulation and removing obstructions in channels |
| CN102579610B (en) * | 2012-04-01 | 2013-09-11 | 李伟丽 | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof |
| CN102579610A (en) * | 2012-04-01 | 2012-07-18 | 许从玉 | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof |
| CN103083451A (en) * | 2013-02-21 | 2013-05-08 | 河南中医学院 | Traditional Chinese medical ointment for treating shoulder-hand syndrome as well as preparation method thereof |
| CN103340998A (en) * | 2013-07-29 | 2013-10-09 | 邓森林 | Hand tremble rehabilitation capsules |
| CN104013820A (en) * | 2014-07-01 | 2014-09-03 | 济南高达信息技术有限公司 | Traditional Chinese medicine decoction for treating sequela of cerebral apoplexy |
| CN104622981A (en) * | 2015-01-20 | 2015-05-20 | 甘肃省中医药研究院 | Preparation method of traditional Chinese medicine granules for treating cerebral apoplexy |
| CN104622981B (en) * | 2015-01-20 | 2017-05-03 | 甘肃省中医药研究院 | Preparation method of traditional Chinese medicine granules for treating cerebral apoplexy |
| CN105434513A (en) * | 2016-01-03 | 2016-03-30 | 岑溪市坤发液体燃烧炉具有限公司 | Medicated wine for treating stroke sequelae |
| CN109260368A (en) * | 2018-09-26 | 2019-01-25 | 陈晓虎 | The pharmaceutical composition and preparation method thereof for preventing and treating acute coronary syndrome |
| CN109260368B (en) * | 2018-09-26 | 2022-06-10 | 江苏省中医院 | Pharmaceutical composition for preventing and treating acute coronary syndrome and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN103142953A (en) | Foot-bath health-protective Chinese medicament powder | |
| CN1182604A (en) | Ointment for treating apoplexy | |
| CN100376229C (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN102614387A (en) | Traditional Chinese medicine for prevention and treatment of stroke and preparation method thereof | |
| CN101940751A (en) | Traditional Chinese medicinal preparation for treating sequela of cerebral infarction | |
| CN102813839A (en) | Compound medicine for treating cluster headache syndrome | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN103520366B (en) | Be used for the treatment of the Chinese medicine of spastic hemiplegia after stroke | |
| CN1840004A (en) | Blood-activating stasis-resolving mixture and preparation method thereof | |
| CN101926976B (en) | Pill for treating angiitis | |
| CN100355450C (en) | Qinchuan Tongbi tablet | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1232693A (en) | Health beverage for preventing and curing hypertension and hyperlipemia | |
| CN103316228A (en) | Scorpio unsting wine | |
| CN102114211B (en) | Chinese herbal medicine for treating hepatitis | |
| CN102406870A (en) | Medicine for treating rheumatic arthralgia | |
| CN1672699A (en) | Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn | |
| CN102397363A (en) | Traditional Chinese medicine for treating hypertension | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1308952A (en) | Chinese medicine for treating trigeminal neuraligia and its preparing process | |
| CN1277577C (en) | Chinese traditional medicine for treating cerebral thrombosis, preparation method and application | |
| CN1122520C (en) | Osteanaphysis capsule for treating femoral head necrosis | |
| CN103127283A (en) | Medicine for treating pelvic inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |